Detalhe da pesquisa
1.
Results of the first international quality control programme for oral targeted oncolytics.
Br J Clin Pharmacol
; 90(1): 336-343, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776845
2.
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview.
Lancet Oncol
; 23(9): e406-e415, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055309
3.
Body weight gain in clozapine-treated patients: Is norclozapine the culprit?
Br J Clin Pharmacol
; 88(2): 853-857, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355423
4.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update.
Lancet Oncol
; 24(6): e229, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269847
5.
QT prolongation with anticancer drugs: a multimodal issue - Authors' reply.
Lancet Oncol
; 23(12): e523, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455572
6.
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
Cancers (Basel)
; 15(11)2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296838
7.
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry.
Drug Saf
; 44(5): 581-588, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538994
8.
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients.
Expert Opin Drug Saf
; 19(12): 1617-1624, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32990050